James B. Young

Active 1977–2024

198
Papers
58,534
Citations
121
h-index
195
i10-index

Citations

Citations per year for James B. Young1964: 1 citations1976: 1 citations1977: 1 citations1978: 4 citations1979: 14 citations1980: 13 citations1981: 14 citations1982: 37 citations1983: 62 citations1984: 50 citations1985: 22 citations1986: 46 citations1987: 34 citations1988: 31 citations1989: 48 citations1990: 51 citations1991: 48 citations1992: 40 citations1993: 48 citations1994: 44 citations1995: 61 citations1996: 77 citations1997: 119 citations1998: 145 citations1999: 154 citations2000: 184 citations2001: 221 citations2002: 225 citations2003: 279 citations2004: 312 citations2005: 388 citations2006: 368 citations2007: 359 citations2008: 402 citations2009: 442 citations2010: 512 citations2011: 423 citations2012: 443 citations2013: 459 citations2014: 442 citations2015: 403 citations2016: 407 citations2017: 388 citations2018: 293 citations2019: 1,166 citations2020: 1,140 citations2021: 985 citations2022: 682 citations2023: 432 citations2024: 700 citations2025: 276 citations2026: 8 citations1965–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,738 citing papers, 29.4% of this breakdownUnited Kingdom: 1,430 citing papers, 7.3% of this breakdownItaly: 1,273 citing papers, 6.5% of this breakdownGermany: 1,056 citing papers, 5.4% of this breakdownCanada: 882 citing papers, 4.5% of this breakdownNetherlands: 764 citing papers, 3.9% of this breakdownFrance: 600 citing papers, 3.1% of this breakdownChina: 590 citing papers, 3% of this breakdownJapan: 528 citing papers, 2.7% of this breakdownAustralia: 487 citing papers, 2.5% of this breakdownSweden: 473 citing papers, 2.4% of this breakdownSpain: 468 citing papers, 2.4% of this breakdown
0%29.4%Other 26.9%

Fields

  • Medicine79.3%
  • Engineering8.7%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Neuroscience2%
  • Immunology and Microbiology1.2%
  • Nursing0.5%
  • Other3.4%

Topics

  • Heart Failure Treatment and Management8.3%
  • Cardiovascular Function and Risk Factors6.5%
  • Mechanical Circulatory Support Devices3.9%
  • Cardiac Structural Anomalies and Repair2.8%
  • Cardiac pacing and defibrillation studies2.8%
  • Transplantation: Methods and Outcomes2.1%
  • Other73.6%

Coauthors

All papers

Open in search
  1. Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure

    Authors: , , , , , , , - Journal of the American College of Cardiology 2009 cited by 1,630

  2. Contemporary Definitions and Classification of the Cardiomyopathies

    Authors: , , , , , , , , - Circulation 2006 cited by 3,411

  3. Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial

    Authors: , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2011 cited by 551

  4. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

    Authors: , , , , , , , , , , , , - European Heart Journal 2008 cited by 710

  5. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 591

  6. Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2007 cited by 1,091

  7. Cytokines and Cytokine Receptors in Advanced Heart Failure

    Authors: , , , , , - Circulation 2001 cited by 1,007

  8. Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study

    Authors: , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 cited by 718

  9. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events

    Authors: , , , , , , , , , - The Journal of Heart and Lung Transplantation 2017 cited by 1,236

  10. INTERMACS Profiles of Advanced Heart Failure: The Current Picture

    Authors: , , , , , , , , , - The Journal of Heart and Lung Transplantation 2009 cited by 791

  11. Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure

    Authors: , , , , , , , , , - Journal of the American College of Cardiology 2008 cited by 598

  12. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure

    Authors: , , , , , , , , , , - JAMA 2006 cited by 970

  13. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure

    Authors: , , , , , , , , , , - Circulation 2007 cited by 673

  14. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

    Authors: , , , , , - Journal of the American College of Cardiology 1996 cited by 1,210

  15. Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2004 cited by 397

  16. Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure

    Authors: , , , , , , , , , - Circulation 2006 cited by 607

  17. Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

    Authors: , , , , , , , , , , , , - JACC Heart Failure 2013 cited by 434

  18. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

    Authors: , , , , , , , , , , - 2003 cited by 1,620

  19. Seventh INTERMACS annual report: 15,000 patients and counting

    Authors: , , , , , , , , , - The Journal of Heart and Lung Transplantation 2015 cited by 1,358

  20. Cause of death in clinical research

    Authors: , , , - Journal of the American College of Cardiology 1999 cited by 595

  21. The Interaction of Sex, Height, and QRS Duration on the Effects of Cardiac Resynchronization Therapy on Morbidity and Mortality: An Individual-Patient Data Meta-Analysis

    Authors: , , , , , , , - European Journal of Heart Failure 2018 cited by 112

  22. High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults

    Authors: , , , , , , , - Circulation 2001 cited by 679

  23. Just Imagine

    Authors: , , , - Academic Medicine 2013 cited by 334

  24. Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM

    Authors: , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2006 cited by 247